|
|
||||||||
Ann Thorac Surg 1984;38:287-291
© 1984 The Society of Thoracic Surgeons
First Department of Surgery, Osaka University Medical School, Osaka, Japan the Second Department of Surgery, Nagoya City University Medical School, Nagoya, Japan
Accepted for publication February 20, 1984.
* Address reprint requests to Dr. Monden, First Department of Surgery, Osaka University Medical School, Osaka 553, Japan
In 80 patients with type II nonthymomatous myasthenia gravis who underwent extended thymectomy, we investigated preoperative duration of symptoms, prognosis after thymectomy, immunological findings, and germinal center formation in the thymus. Our findings included the following. First, the palliation rate after thymectomy ranged from 73 to 100% and was independent of the preoperative duration of symptoms. The remission rate was high in patients with a short preoperative duration. Second, the lymphocyte count of peripheral blood decreased as preoperative duration increased. Third, the percentage of positive reactions to purified protein derivative of tuberculin decreased as preoperative duration increased: 100% in the one-year group, 78% in the two-year group, 75% in the three-year group, and 56% in the four-year group. Fourth, the degree of germinal center formation in the thymus was higher in patients with a longer preoperative duration. The correlation between germinal center formation and preoperative duration was significant. Finally, the T-cell population in peripheral blood and immunoglobulin, and antibody to acetylcholine receptor in serum, had no significant relationship with the preoperative duration of myasthenia gravis.
This article has been cited by other articles:
![]() |
C. Cheng, G. Wu, S.-C. J. Yeung, R. Li, A. E. Bella, J. Pang, F.-t. Zhong, H. Luo, Y. Jin, and J. Pan Serum Protein Profiles in Myasthenia Gravis Ann. Thorac. Surg., October 1, 2009; 88(4): 1118 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kattach, K. Anastasiadis, J. Cleuziou, C. Buckley, B. Shine, R. Pillai, and C. Ratnatunga Transsternal Thymectomy for Myasthenia Gravis: Surgical Outcome Ann. Thorac. Surg., January 1, 2006; 81(1): 305 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Gronseth and R. J. Barohn Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, July 12, 2000; 55(1): 7 - 15. [Full Text] [PDF] |
||||
![]() |
M. Tsuchida, Y. Yamato, T. Souma, K. Yoshiya, T. Watanabe, T. Aoki, and J.-i. Hayashi Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis Ann. Thorac. Surg., June 1, 1999; 67(6): 1563 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Masaoka, Y. Yamakawa, H. Niwa, I. Fukai, S. Kondo, M. Kobayashi, Y. Fujii, and Y. Monden Extended Thymectomy for Myasthenia Gravis Patients: A 20-Year Review Ann. Thorac. Surg., September 1, 1996; 62(3): 853 - 859. [Abstract] [Full Text] |
||||
![]() |
H. Nakamura, Y. Taniguchi, Y. Suzuki, Y. Tanaka, K. Ishiguro, M. Fukuda, H. Hara, and T. Mori DELAYED REMISSION AFTER THYMECTOMY FOR MYASTHENIA GRAVIS OF THE PURELY OCULAR TYPE J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 371 - 375. [Abstract] [Full Text] |
||||
![]() |
Y. Monden, T. Uyama, K. Nakahara, Y. Fujii, J. Hashimoto, K. Ohno, A. Masaoka, and Y. Kawashima Clinical Characteristics and Prognosis of Myasthenia Gravis with Other Autoimmune Diseases Ann. Thorac. Surg., February 1, 1986; 41(2): 189 - 192. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |